BioSpace News Archive

Intec Pharma Ltd. announces that two posters in support of the Company’s Phase 3 clinical development program for the Accordion Pill™ Carbidopa/Levodopa, will be presented at the upcoming International Congress of Parkinson’s and Movement Disorder Society being held from September 22-26, 2019 in Nice, France.

Proton Therapy Partners has named Kurt Morath its Vice President of Operations.

Industry veteran brings extensive experience leading business development

CytoSorbents Corporation announced that Hannover Medical School in Germany will begin the first clinical study called CYTORELEASE, evaluating the use of CytoSorb in treating CRS and inflammation of the brain called CAR-related Encephalopathy Syndrome, following CAR-T cell immunotherapy.

Study Investigates Use of the Tack Endovascular System® for Focal Dissection Repair Following Drug-Coated Balloon Angioplasty in PAD Patients

SWK Holdings Corporation, a life science focused specialty finance company, announced that CEO Winston Black will present at the Fall Investor Summit being held in New York City.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the Company has initiated APOLLO-B, a global Phase 3 placebo-controlled clinical trial of patisiran, an intravenously administered RNAi therapeutic, for the treatment of transthyretin amyloidosis (ATTR amyloidosis) with cardiomyopathy.

A breakthrough approach for treatment of autoimmune and inflammatory diseases

Centene Corporation (NYSE: CNC) announced today it will present at the Cantor Global Healthcare Conference, to be held October 2-4, 2019, at the Intercontinental New York Barclay Hotel in New York City.

Varian (NYSE: VAR) today announced its ProBeam 360° proton therapy system is now available in a multi-room configuration.